AstraZeneca is a global, science-led, patient-focused biopharmaceutical company dedicated to the discovery, development, and commercialization of prescription medicines for serious diseases. Within Hematology R&D, the team is committed to advancing science to deliver life-changing medicines for patients in need. The Hematology Research and Early Development (R&D) team is responsible for all drug development activities in hematology research, from first-in-man studies to late-stage trials leading to regulatory approval (Phase 1, 2, and 3). The team aims to deliver robust preclinical, clinical, and translational data packages to support investment in late-stage clinical development and drug approval. This role is for a highly qualified Global Clinical Program Lead (GCPL) to lead the clinical development and execution of product strategy for multiple projects. The individual will report to the Global Clinical Head (GCH) of the disease indication and will be responsible for articulating project goals, strategy, and the underlying science and clinical need to both internal and external audiences. The GCPL will collaborate with other project leaders, scientific and clinical leaders, and external experts to coordinate integrated project plans across functional boundaries, ensuring diverse team views are heard and fostering an empowered and motivated team. Demonstrated leadership within the oncology community, both internally and externally, is expected, along with hematology/oncology clinical drug development experience and the ability to critically navigate the science underlying these programs. Effective communication across a broad range of audiences and the ability to articulate project-specific and overall oncology strategies are essential.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree